These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 21180298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 4. Beta blockers in coronary artery disease with and without hypertension.
    Guha S, Ray S.
    Indian Heart J; 2010 Oct; 62(2):126-31. PubMed ID: 21180302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A, Divchev D, Luchtefeld M, Schieffer B.
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [Abstract] [Full Text] [Related]

  • 7. beta-Blocker therapy in heart failure.
    Doughty RN.
    Heart Fail Monit; 2000 Dec; 1(1):2-7. PubMed ID: 12634875
    [Abstract] [Full Text] [Related]

  • 8. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM.
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [Abstract] [Full Text] [Related]

  • 9. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F.
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Aug; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 12. Experience with beta blockers in heart failure mortality trials.
    Eichhorn EJ.
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V21-9. PubMed ID: 10526700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.
    Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
    [Abstract] [Full Text] [Related]

  • 16. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
    Bangalore S, Wild D, Parkar S, Kukin M, Messerli FH.
    J Am Coll Cardiol; 2008 Sep 23; 52(13):1062-72. PubMed ID: 18848139
    [Abstract] [Full Text] [Related]

  • 17. Bisoprolol and heart failure: new frontiers.
    Chopra HK.
    Indian Heart J; 2010 Sep 23; 62(1):7-12. PubMed ID: 21180027
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.